# FDA Inspection 1229211 - Homeocare Laboratories, Inc. - March 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/homeocare-laboratories-inc/383a06ea-8b63-44fd-bceb-42db2acbe1a6
Source feed: FDA_Inspections

> FDA Inspection 1229211 for Homeocare Laboratories, Inc. on March 20, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229211
- Company Name: Homeocare Laboratories, Inc.
- Inspection Date: 2024-03-20
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1197967 - 2023-02-21](https://www.keypedia.com/records/fda_inspections/homeocare-laboratories-inc/c4c2a00b-51d6-4ada-855f-5672fbf8fa63)
- [FDA Inspection 1144657 - 2021-06-04](https://www.keypedia.com/records/fda_inspections/homeocare-laboratories-inc/48731717-626b-4fc5-aed9-10cf73470ccf)
- [FDA Inspection 1042013 - 2018-02-23](https://www.keypedia.com/records/fda_inspections/homeocare-laboratories-inc/90a43408-330c-4c25-9dc8-04109391df42)
- [FDA Inspection 997603 - 2017-01-11](https://www.keypedia.com/records/fda_inspections/homeocare-laboratories-inc/252670c0-e465-4a68-8bea-56aa24bc0582)

Company: https://www.keypedia.com/companies/homeocare-laboratories-inc/c4464988-ca0b-4146-b817-3dfb461a073e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c